Detalhe da pesquisa
1.
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.
Cancer Immunol Immunother;
70(12): 3541-3555, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33903973
2.
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target.
J Drug Target;
32(3): 223-240, 2024 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252514
3.
Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
World J Gastroenterol;
28(41): 5968-5981, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36405111
4.
Optimization of the Administration Strategy for the Armed Oncolytic Adenovirus ZD55-IL-24 in Both Immunocompromised and Immunocompetent Mouse Models.
Hum Gene Ther;
32(23-24): 1481-1494, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34155929
5.
The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing.
Cell Death Dis;
11(11): 1022, 2020 11 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33257647
6.
[The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population].
Zhonghua Yu Fang Yi Xue Za Zhi;
43(10): 903-6, 2009 Oct.
Artigo
em Zh
| MEDLINE
| ID: mdl-20137473